基本資料
種類: ETF
費用比率%: 0.54
資產淨值: 46.63
成立日期: 30/10/2024
 
分析
市值分佈:
64.27%
大市值
22.10%
中市值
2.11%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 25/07/2026 05:40) 總持有投資項目: 33  
0%
 
100%
     10大 (56.21%)
代號 名稱 佔比% 持有日期
TVTXTravere Therapeutics8.0530/06/2026
COGTCogent Biosciences7.2630/06/2026
LIVNLivaNova PLC6.9130/06/2026
SYRESpyre Therapeutics6.7530/06/2026
GHGuardant Health5.5630/06/2026
CORTCorcept Therapeutics5.2330/06/2026
MIRMMirum Pharmaceuticals4.9530/06/2026
BLLNBilliontoone Inc4.2930/06/2026
MANEVeradermics Inc3.6330/06/2026
TRVITrevi Therapeutics3.5830/06/2026
SVRASavara3.3330/06/2026
NKTRNektar Therapeutics2.9530/06/2026
DNTHDianthus Therapeutics2.8230/06/2026
TMDXTransMedics Group2.3130/06/2026
PVLAPalvella Therapeutics Inc2.1930/06/2026
CRVSCorvus Pharmaceuticals2.0530/06/2026
VRDNViridian Therapeutics2.0330/06/2026
ICUIICU Medical1.9730/06/2026
TWSTTwist Bioscience Corp1.5230/06/2026
CBLLCERIBELL INC1.4330/06/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.